I. Keun Choi, Y. Hong Kim, J. Suk Kim, and J. Hong Seo, “High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer”, AO, vol. 49, no. 6, pp. 861–864, Aug. 2010.